P4HB (Protein | Antibody | cDNA Clone | ELISA Kit)

All P4HB reagents are produced in house and quality controlled, including 12 P4HB Antibody, 2 P4HB ELISA, 26 P4HB Gene, 4 P4HB IP Kit, 2 P4HB Lysate, 2 P4HB Protein, 2 P4HB qPCR. All P4HB reagents are ready to use.

P4HB Protein (2)

    P4HB Antibody (12)

      P4HB ELISA Kit & Match Antibody ELISA Pair Set (2)

      P4HB cDNA Clone (26)

      NM_000918.3
      NM_011032.2

      P4HB Lysate (2)

        More Product Popular With Customers

        P4HB Background

        Protein disulfide-isomerase, also known as Cellular thyroid hormone-binding protein, Prolyl 4-hydroxylase subunit beta, p55 and P4HB, is a peripheral membrane protein which belongs to the protein disulfide isomerase family. P4HB is highly abundant. In some cell types, it seems to be also secreted or associated with the plasma membrane, where it undergoes constant shedding and replacement from intracellular sources. P4HB localizes near CD4-enriched regions on lymphoid cell surfaces. It is identified by mass spectrometry in melanosome fractions from stage I to stage IV. P4HB reduces and may activate fusogenic properties of HIV-1 gp12 surface protein, thereby enabling HIV-1 entry into the cell. P4HB catalyzes the formation, breakage and rearrangement of disulfide bonds. At the cell surface, it seems to act as a reductase that cleaves disulfide bonds of proteins attached to the cell. P4HB may therefore cause structural modifications of exofacial proteins. Inside the cell, it seems to form/rearrange disulfide bonds of nascent proteins. At high concentrations, P4HB functions as a chaperone that inhibits aggregation of misfolded proteins. At low concentrations, it facilitates aggregation (anti-chaperone activity). P4HB may be involved with other chaperones in the structural modification of the TG precursor in hormone biogenesis. It also acts a structural subunit of various enzymes such as prolyl 4-hydroxylase and microsomal triacylglycerol transfer protein MTTP.

        P4HB References

        • Kivirikko KI, et al., 1989, FASEB J., 3 (5): 1609-17.
        • Pihlajaniemi T, et al.,1991, J Hepatol., 13, Suppl 3: S2
        • Fenouillet E., et al., 2001, J. Infect. Dis. 183:744-752.
        • Gevaert K., et al., 2003, Nat. Biotechnol. 21:566-569.
        • Barbouche R., et al., 2003, J. Biol. Chem. 278:3131-3136.